MADRIGAL PHARMACEUTICALS
Madrigal Pharmaceuticals is developing novel, high-quality small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. The Company is targeting treatment of both niche and prevalent indications, including diabetes, dyslipidemia and cardiovascular disease.
MADRIGAL PHARMACEUTICALS
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
2011-01-01
Address:
Washington, Pennsylvania, United States
Country:
United States
Website Url:
http://www.madrigalpharma.com
Total Employee:
1+
Status:
Active
Contact:
(267) 327-4445
Email Addresses:
[email protected]
Total Funding:
288.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins Nginx IPv6
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Madrigal Pharmaceuticals
Bay City Capital
Bay City Capital investment in Post-IPO Equity - Madrigal Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-10 | Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics Officer |
Official Site Inspections
http://www.madrigalpharma.com Semrush global rank: 2.78 M Semrush visits lastest month: 5.83 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Madrigal Pharmaceuticals"
Home - Madrigal
Jul 22, 2025 Delivering a Breakthrough Treatment Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis …See details»
Madrigal Pharmaceuticals Org Chart + Executive Team
The org chart of Madrigal Pharmaceuticals contains its 32 main executives like Bill Sibold, Mardi Dier and Mark Barrett.See details»
Madrigal Pharmaceuticals (MDGL) Company Profile & Description
2 days ago Company profile for Madrigal Pharmaceuticals, Inc. (MDGL) stock, with a description, list of executives, contact details and other key facts.See details»
Madrigal Pharmaceuticals - Crunchbase Company …
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.See details»
Madrigal Medical Affairs – A clinical-stage …
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction steatohepatitis (MASH/NASH).See details»
About Madrigal - Madrigal
About Madrigal A madrigal is a form of Renaissance choral music known for beautiful harmonies. At Madrigal Pharmaceuticals, our work focuses on restoring balance and harmony to the liver, …See details»
Madrigal Pharmaceuticals Inc - Company Profile - GlobalData
Madrigal Pharmaceuticals Inc (Madrigal) is a biopharmaceutical company that focuses on developing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as …See details»
Our Leaders - Madrigal
Working at Madrigal Interested in making a difference in the lives of people living with MASH? Join our talented, diverse and dedicated team.See details»
Madrigal Pharmaceuticals (LON:0JXI) Company Profile & Description
Jul 22, 2025 Company profile for Madrigal Pharmaceuticals, Inc. (LON:0JXI) with a description, list of executives, contact details and other key facts.See details»
Madrigal Pharmaceuticals Announces Leadership Transition
Apr 16, 2025 Madrigal Pharmaceuticals announces management changes, with Rebecca Taub transitioning to Senior Scientific Advisor and David Soergel as Chief Medical Officer.See details»
Madrigal Pharmaceuticals Appoints Bill Sibold as Chief
Sep 11, 2023 From 2017 until joining Madrigal, Mr. Sibold served as Executive Vice President, Specialty Care of Sanofi and President, Sanofi North America, where he led a global …See details»
Overview | Madrigal Pharmaceuticals, Inc.
Jul 16, 2025 The Investor Relations website contains information about Madrigal Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Madrigal Pharmaceuticals Enters into Exclusive Global License …
1 day ago The Investor Relations website contains information about Madrigal Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Community - Madrigal
The Fatty Liver Foundation is the only national, non-profit, patient organization dedicated to improving the identification, diagnosis, treatment and support of Americans with fatty liver, …See details»
Corporate Governance | Madrigal Pharmaceuticals, Inc.
The Investor Relations website contains information about Madrigal Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Our Medicine - Madrigal
For Patients Patient Information For Healthcare Professionals Prescribing Information For U.S. audiences only Madrigal Patient Support Support for patients along every step of their journey, …See details»
Press Releases | Madrigal Pharmaceuticals, Inc.
May 1, 2025 Find the latest press releases and updates from Madrigal Pharmaceuticals, a biopharmaceutical company focused on liver-directed therapies for serious liver diseases.See details»
Financials and Filings | Madrigal Pharmaceuticals, Inc.
Feb 25, 2021 The Investor Relations website contains information about Madrigal Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial …
Mar 31, 2025 Madrigal Pharmaceuticals shares first-quarter 2025 financial results and updates on its progress in developing novel therapeutics for liver diseases.See details»
Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial …
Sep 30, 2024 The Investor Relations website contains information about Madrigal Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»